ArticleFrontiers in behavioral neuroscience2026
A mouse model of oxycodone reward following its oral self-administration in a sweetened solution.
Article in Frontiers in behavioral neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study aimed to develop a preclinical model in which reinforcement and reward can be measured in the same subject. To this end, we combined the power of drug self-administration and place conditioning paradigms and determined whether voluntary oral oxycodone self-administration would induce conditioned place preference (CPP) and whether this response could be extinguished and reinstated. To assess the face validity of the model, we also evaluated the role of the mu-opioid receptor (MOP) in this process. Methods: Male and female C57BL/6 mice, as well as male MOP knockout mice and their wild-type littermates, were initially conditioned with sucrose (4%) in both conditioning chambers for 1 h daily for 2 weeks (4 days a week). Mice were then tested for basal place preference and then underwent alternate-day conditioning (1 h daily) with sucrose (4%) in one chamber and oxycodone in a 4% sucrose solution in the opposite chamber the following day for four consecutive days, followed by a CPP test. The following week, another set of conditioning and testing for CPP was repeated. Subsequently, mice were exposed to the sucrose (45) solution alone for 4 days each week, and a test for extinction of the CPP response at the end of each week. After extinction, mice were challenged with oxycodone (5 mg/kg) and tested for the reinstatement of CPP. Results: Both male and female mice demonstrated robust voluntary oral oxycodone self-administration in a 4% sucrose solution, but it was lower in females than in males. Oxycodone self-administration was associated with CPP in male and female mice. This response was extinguished and reinstated. Unlike wild-type mice, the CPP response was not observed in mice lacking MOP, suggesting that MOP is involved in this response. Discussion: This is the first study providing evidence for the development of a translational mouse model of reward utilizing oral oxycodone self-administration in a sweetened solution.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.